<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) and <z:chebi fb="0" ids="25941">peroxynitrite</z:chebi>, formed from NO and <z:chebi fb="1" ids="18421">superoxide</z:chebi> <z:chebi fb="5" ids="22563">anion</z:chebi>, have been implicated as mediators of neuronal damage following focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, but their molecular targets have not been defined </plain></SENT>
<SENT sid="1" pm="."><plain>One candidate pathway is DNA damage leading to activation of the nuclear enzyme, poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) polymerase (PARP), which catalyzes attachment of <z:chebi fb="13" ids="16761">ADP</z:chebi> <z:chebi fb="1" ids="33942">ribose</z:chebi> units from <z:chebi fb="0" ids="13389">NAD</z:chebi> to nuclear proteins following DNA damage </plain></SENT>
<SENT sid="2" pm="."><plain>Excessive activation of PARP can deplete <z:chebi fb="0" ids="13389">NAD</z:chebi> and ATP, which is consumed in regeneration of <z:chebi fb="0" ids="13389">NAD</z:chebi>, leading to cell <z:hpo ids='HP_0011420'>death</z:hpo> by energy <z:mpath ids='MPATH_63'>depletion</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>We show that genetic disruption of PARP provides profound protection against <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-NO-mediated ischemic insults in vitro and major decreases in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume after reversible middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>These results provide compelling evidence for a primary involvement of PARP activation in neuronal damage following focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and suggest that therapies designed towards inhibiting PARP may provide benefit in the treatment of cerebrovascular disease </plain></SENT>
</text></document>